It's indisputable the AFR uncovered facts not generally known in the marketplace regarding BIG that carried clear negative ramifications that were not factored into investor sentiment and market price.
The sheer traction of the article in terms of share price movement, ASX suspension, regulatory action etc testify this. It's indisputable.
Why wouldn't you pay a premium subscription for such "market moving" research and analysis ? The answer is: obviously everyone in their right mind would.
At the moment unfortunately your comprehension of what is going on is affected by your bias as a holder of the stock. Objectivity is out the window and you attack anything and everything that counters your positive outlook.
- Forums
- ASX - By Stock
- BIG
- Latest AFR Article
Latest AFR Article, page-123
-
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online